{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:17:42Z","timestamp":1791105462094,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ophtha.2009.02.002","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T04:45:36Z","timestamp":1241412336000},"page":"902-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema"],"prefix":"10.1016","volume":"116","author":[{"given":"Taygan","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal J.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cordero-Coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene A.","family":"Cervantes-Castaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Klisovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Lavaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2009.02.002_bib1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report no. 1","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.02.002_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV","volume":"102","author":"Klein","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2009.02.002_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib5","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib6","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1167\/iovs.05-0297","article-title":"Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial","volume":"46","author":"Bonini-Filho","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2009.02.002_bib7","first-page":"1747","article-title":"Macugen Diabetic Retinopathy Study Group","volume":"112","author":"Cunningham","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ophtha.2006.12.028","article-title":"Pan-American Collaborative Retina Study Group","volume":"114","author":"Arevalo","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2006.04.033","article-title":"A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema","volume":"113","author":"Chun","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10384-006-0366-5","article-title":"Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide","volume":"50","author":"Higuchi","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.02.002_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0161-6420(87)33527-4","article-title":"Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 2","volume":"94","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib12","first-page":"1447","article-title":"Diabetic Retinopathy Clinical Research Network","volume":"115","author":"Elman","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.02.002_bib16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ophtha.2006.08.044","article-title":"Evaluation of intravitreal Kenalog toxicity in humans","volume":"114","author":"Lang","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ophtha.2009.02.002_bib18","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2009.02.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2009.02.002_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2005.03.023","article-title":"Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema","volume":"112","author":"Cardillo","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1600-0420.2006.00700.x","article-title":"Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial","volume":"84","author":"Audren","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2009.02.002_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10792-007-9097-y","article-title":"A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema","volume":"28","author":"Dehghan","year":"2008","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.02.002_bib23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial","volume":"113","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.02.002_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2006.22.200","article-title":"Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study","volume":"22","author":"Jonas","year":"2006","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:58:00Z","timestamp":1758981480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642009001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0161642009001213"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.02.002","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}